Motomura, Kazuyoshi <br/><br/>
Expression of estrogen receptor beta and phosphorylation of estrogen receptor alpha serine 167 correlate with progression-free survival in patients with metastatic breast cancer treated with aromatase inhibitors.  [electronic resource] 

 -  Oncology  2010 
 - 55-61 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1423-0232 
<br/><br/><label>Standard No.: </label>10.1159/000319540  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anastrozole<br/>Androstadienes--therapeutic use<br/>Antineoplastic Agents, Hormonal--therapeutic use<br/>Aromatase Inhibitors--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>Disease-Free Survival<br/>Estrogen Receptor alpha--metabolism<br/>Estrogen Receptor beta--metabolism<br/>Fadrozole--therapeutic use<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Immunohistochemistry<br/>Kaplan-Meier Estimate<br/>Middle Aged<br/>Nitriles--therapeutic use<br/>Phosphorylation<br/>Predictive Value of Tests<br/>Prognosis<br/>Retrospective Studies<br/>Serine--metabolism<br/>Tamoxifen--therapeutic use<br/>Triazoles--therapeutic use